Bioengineering: From Mechanics and Devices to Tissue Engineering and Genetics

Author(s):  
Winfred M. Phillips

Abstract The National Institutes of Health (NIH) defines bioengineering as an interdisciplinary field that applies physical, chemical, and mathematical sciences and engineering principles to the study of biology, medicine, behavior, and health. Bioengineering advances knowledge from the molecular to the organ systems level, and develops new and novel biologics, materials, processes, implants, devices, and informational approaches for the prevention, diagnosis, and treatment of disease, for patient rehabilitation, and for improving health. Enormous contributions to the advancement of health care have been made through bioengineering. It has been instrumental in establishing the United States as the world leader in health care technology, as evidenced by a $4.6 billion trade surplus for this sector in 1993. The field, through basic and applied research and technology assessment, has given us such devices as the pacemaker, orthopedic implants, and noninvasive diagnostic imaging. Bioengineers have developed new processes for manufacturing products in the pharmaceutical and biotechnology industries. An example is the manufacturing of human insulin, the first product based on recombinant DNA technology, where bioengineering was critical to the ability to commercialize the product. These continuing contributions and unprecedented growth, focus, and opportunity in bioengineering will be a continuing frontier and opportunity for the United States and the world.

PEDIATRICS ◽  
1991 ◽  
Vol 88 (2) ◽  
pp. 401-405
Author(s):  

Clinical studies of component ("acellular") pertussis vaccines have been undertaken in recent years, and several acellular vaccines have been used in Japan for 10 years. The Committee has reviewed these trials and related data and herein provides its assessment regarding the current status of the acellular vaccines and their possible use in the United States. The pertussis vaccines in current use in the United States are prepared from whole cells of a strain of Bordetella pertussis that is grown in broth medium, harvested by centrifugation, and killed or partially detoxified by heat or by the addition of a chemical agent, such as thimerosal, or by a combination of these methods. In contrast, the acellular vaccines developed in Japan and used in that country since 1981 contain one or more antigens derived from biologically active components of the B pertussis organism.1 An inactivated form of lymphocytosis promoting factor (LPF), also known as pertussis toxin and a variety of other synonyms, is a frequent component of acellular pertussis vaccines, as are filamentous hemagglutinins (FHA). Other constituents included in acellular vaccines are agglutinogens, a term denoting a variety of protein antigens on the surface of the B pertussis organism. Of the agglutinogens, a 69-kd outer membrane protein, when injected into neonatal mice, protects against B pertussis challenge.2 Acellular vaccines also have recently been derived from mutant pertussis toxin molecules prepared with recombinant DNA technology.3 The acellular vaccines produced in Japan have been classified into two types: B type, which contains LPF and FHA in roughly equal amounts; and T type, which contains mostly FHA but some LPF and agglutinogens.1,4


2009 ◽  
Vol 39 (2) ◽  
pp. 363-387 ◽  
Author(s):  
Nicholas Skala

The collapse of the World Trade Organization's (WTO) Doha Round of talks without achieving new health services liberalization presents an important opportunity to evaluate the wisdom of granting further concessions to international investors in the health sector. The continuing deterioration of the U.S. health system and the primacy of reform as an issue in the 2008 presidential campaign make clear the need for a full range of policy options for addressing the national health crisis. Yet few commentators or policymakers realize that existing WTO health care commitments may already significantly constrain domestic policy options. This article illustrates these constraints through an evaluation of the potential effects of current WTO law and jurisprudence on the implementation of a single-payer national health insurance system in the United States, proposed incremental national and state health system reforms, the privatization of Medicare, and other prominent health system issues. The author concludes with some recommendations to the U.S. Trade Representative to suspend existing liberalization commitments in the health sector and to interpret current and future international trade treaties in a manner consistent with civilized notions of health care as a universal human right.


2016 ◽  
Vol 21 (7) ◽  
pp. 2051-2060 ◽  
Author(s):  
Sylvia Mignon

Abstract Health care within jails and prisons in the United States is typically insufficient to meet the medical and psychological needs of female inmates. Health services are often of low quality, especially in the areas of reproductive medicine. Mental illness, substance abuse, a trauma history, and sexual victimization while incarcerated can predict a more difficult adjustment to a correctional environment. Incarcerated women who are able to maintain contact with family members, especially children, can have a better prison adjustment. Recommendations are made to improve the types and quality of health care delivered to women in jails and prisons in countries around the world.


2002 ◽  
Vol 96 (1) ◽  
pp. 1-4 ◽  
Author(s):  
José E. Alvarez

A burgeoning literature addresses the links between the World Trade Organization and ostensibly “nontrade” issues, including corruption and bribery, health care (such as tobacco control), human rights generally or labor rights in particular, diverse environmental concerns, issues of “culture,” and even the fight against terrorism. Current WTO scholarship, at least that published in the United States, seems to be obsessed with exploring the outer boundaries of the trade regime. In the face of a vast array of potential recipes for linkage to particular nontrade issues, as well as cautionary tales against such linkage, what is to be gained from revisiting these questions?


1994 ◽  
Vol 24 (2) ◽  
pp. 231-251 ◽  
Author(s):  
Howard Glennerster ◽  
Manos Matsaganis

England and Sweden have two of the most advanced systems of universal access to health care in the world. Both have begun major reforms based on similar principles. Universal access and finance from taxation are retained, but a measure of competition between providers of health care is introduced. The reforms therefore show a movement toward the kind of approach advocated by some in the United States. This article traces the origins and early results of the two countries' reform efforts.


2015 ◽  
Vol 10 ◽  
Author(s):  
Bartolome R. Celli

Chronic obstructive pulmonary disease (COPD) has the dubious distinction of being one of the few major causes of death that continues to rise in the United States and the world. In that sense, its prevention, early diagno- sis when clinically present, and finally its appropriate treatment should constitute a priority item in today’s health care agenda. [...]


2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
◽  

Abstract COVID19 challenges every dimension of public health systems, from research and health care treatment to public communication, coercive mechanisms such as quarantine, and respect for individual rights. This round table has 3 key objectives: To understand patterns in responses across countries, and in particular the different ways that authoritarian and democratic regimes responded;To identify comparative lessons for understanding the European experience from other high-income health systems;To draw conclusions about the politics of effective public health intervention and likely lessons of COVID19. Burris will present on how although initial control efforts took the form of travel restrictions, quarantine and isolation, sustained human-to-human community transmission of COVID-19 in the United States pushed authorities to move from these traditional tools to the challenge of promoting social distancing behavior and managing a surge in demand for health care. These challenges posed new and urgent questions of practical regulation and distributive justice as underlying social disparities created differing levels of vulnerability. This presentation reviews the first six months of the response in the US from a legal and social justice standpoint, focusing on issues of equity. Fafard will analyze the communications role of senior public health officials during the COVID-19 outbreak in five countries; their public messaging across a range of media platforms, including how they deal with misinformation; and the extent to which members of the public receive, understand, and trust this messaging. Kavanagh will discuss how relative democratic and autocratic political institutions have influenced early responses to the novel coronavirus outbreak. Using evidence from process tracing in China, Iran, the United States, South Korea, and Italy, this presentation evaluates the hypothesis advanced or implied by many global public health officials that authoritarian governments have an advantage in disease response Peralta will discuss how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic highlighted the heterogeneity in the measured used for containment and mitigation by governments. Where authoritarian states, that theoretically have more policy options for containment and mitigation, have an advantage in an epidemic event remains unclear. This presentation will compare measures taken by governments and health authorities in five selected authoritarian states and five democracies and evaluate the capacity of epidemic containment. Willison will highlight how political elites in the United States define public health threats; how partisanship and party competition define public health responses, including expenditure and coordination; and how party and media elites draw on established tensions in American politics to frame outbreaks in ways advantageous to the parties. Key messages We will focus on similarities and differences in responses to COVID-19 around the world, highlight effective measures, and reflect on lessons learned in the first few months of this novel coronavirus. We will draw attention to issues of human rights and health equity among government responses. Panelists: Scott Burris Temple University, Philadelphia, USA Contact: [email protected] Patrick Fafard University of Ottawa, Ottawa, Canada Contact: [email protected] Matthew Kavanaugh Global Health Policy & Governance Initiative at the O'Neill Institute for National and Global Health, Washington DC, USA Contact: [email protected] André Peralta-Santos University of Washington, Seattle, USA Contact: [email protected] Charley Willison University of Washington, Seattle, USA Contact: [email protected]


Author(s):  
Rickie Solinger

What does the federal health care reform act of 2010 say about pregnancy, contraception, abortion, and reproductive health care generally? The United States has the most expensive health care system of any country in the world. Medical costs per person and the percentage of...


1969 ◽  
Vol 15 (3) ◽  
Author(s):  
Henry Miller

The largest outbreak of food-borne illness in a decade sickened over 1400 people in various parts of the United States in 2008. Originally thought to be caused by tomatoes contaminated with Salmonella saintpaul, an investigation by federal agencies found that Mexican jalapeno peppers and possibly serrano peppers were the culprits.These sorts of outbreaks are not at all rare: A search for ‘food poisoning’ on the website of the US Centers for Disease Control and Prevention (CDC) (on 10 November 2008) yielded more than 5300 hits, and the CDC estimates that each year 76 million cases of food-borne illness occur and more than 300 000 persons are hospitalised and 5000 die. This raises various questions of importance to consumers. Who or what is responsible for the problem? How does such contamination occur, and what can be done to prevent recurrences?Unfortunately, growers of fresh produce cannot protect us 100 per cent of the time. Modern farming operations – especially the larger ones – already employ strict standards and safeguards designed to keep food free of pathogens. And most often they’re highly effective: Americans’ food is not only the least expensive but also the safest, in the history of humankind.The vast majority of food poisoning results from consumers’ improper handling of food – in particular, from inadequately cooking chicken or permitting the juices from raw poultry to contaminate other foods.Because agriculture is an outdoor activity and subject to myriad unpredictable challenges, there are limits to how safe we can make it. If the goal is to make a cultivated field completely safe from microbial contamination, the only definitive solution is to pave it over and build a parking lot on it. But we’d only be trading very rare agricultural mishaps for fender-benders.Nor can we rely on processors to remove the pathogens from food in every case. The 2006 spinach-based outbreak of illness served as a reminder that our faith in processor labels such as ‘triple washed’ and ‘ready to eat’ must be tempered with at least a little scepticism. Processors were quick to proclaim the cleanliness of their own operations and deflect blame toward growers. But all of those in the food chain share responsibility for food safety and quality.In fairness to processors, there is ample evidence to suggest that no amount of washing will rid produce entirely of all pathogens. The reason is that the contamination may occur not on the plant, but in it. Exposure to Salmonella, E. coli or other microorganisms at key stages of the growing process may allow them to be introduced into the plant's vascular system.In the longer term, technology has an important role – or more accurately, it would have if only the organic food advocates and other activists would permit it. The Food and Drug Administration recently added fresh spinach and iceberg lettuce to the short list of foods that companies can irradiate to kill off many dangerous pathogens. (Regulators had already approved irradiation of meat, poultry, spices, oysters, clams and mussels.) Food irradiation is an important, safe and effective tool that has been vastly under-used, largely due to opposition from the organic food lobby. Their resistance is scandalous – and murderous: ‘If even 50% of meat and poultry consumed in the United States were irradiated, the potential impact of food borne disease would be a reduction [of] 900,000 cases and 300 deaths’, according to Michael Osterholm, Director of the Center for Infectious Disease Research at the University of Minnesota.But irradiation is not a panacea. Although it quite effectively kills the bacteria, it does not inactivate the potent toxins secreted by certain bacteria such as Staphylococcus aureus and Clostridium botulinum, and the approved doses are too low to kill most viruses. The toxins can cause serious illness or death even in the absence of live bacteria themselves.There is technology available today that can both inhibit microorganisms’ ability to grow within plant cells and block the effects of the biochemical and structural features that enable bacteria to cause disease. This same technology can be employed to produce antibodies that can be administered to infected patients to neutralise toxins and other harmful molecules and can even be used to produce therapeutic proteins (such as lactoferrin and lysozyme) that are safe and effective treatments for diarrhoea, the primary symptom of food poisoning.But organic producers won’t embrace this triple-threat technology, even if it would keep their customers from food-borne illness. The technology in question is recombinant DNA technology, or gene-splicing (also known as ‘genetic modification’, or GM) – an advance the organic lobby has repeatedly vilified and rejected.For organic marketers and food activists, the irony is more bitter than fresh-picked radicchio. The technology that offers a potent new weapon to assure the safety of foods is the one they’ve fought hardest to forestall and confound.In view of the huge burden of illnesses and deaths caused by bacteria and viruses in food, will the organic lobby rethink their opposition to biotechnology? Will they begin to appreciate the ways in which this technology can save lives and advance their industry? Will they permit science, common sense and decency to trump ideology? When figs can fly.


2011 ◽  
Vol 23 (4) ◽  
pp. 186-191 ◽  
Author(s):  
Malini Ratnasingam ◽  
Lee Ellis

Background. Nearly all of the research on sex differences in mass media utilization has been based on samples from the United States and a few other Western countries. Aim. The present study examines sex differences in mass media utilization in four Asian countries (Japan, Malaysia, South Korea, and Singapore). Methods. College students self-reported the frequency with which they accessed the following five mass media outlets: television dramas, televised news and documentaries, music, newspapers and magazines, and the Internet. Results. Two significant sex differences were found when participants from the four countries were considered as a whole: Women watched television dramas more than did men; and in Japan, female students listened to music more than did their male counterparts. Limitations. A wider array of mass media outlets could have been explored. Conclusions. Findings were largely consistent with results from studies conducted elsewhere in the world, particularly regarding sex differences in television drama viewing. A neurohormonal evolutionary explanation is offered for the basic findings.


Sign in / Sign up

Export Citation Format

Share Document